Detalhe da pesquisa
1.
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial.
Lancet Oncol
; 24(3): 286-296, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-37052965
2.
Olaparib beyond progression compared with platinum chemotherapy after secondary cytoreductive surgery in patients with recurrent ovarian cancer: phase III randomized, open-label MITO 35b study, a project of the MITO-MANGO groups.
Int J Gynecol Cancer
; 32(6): 799-803, 2022 06 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35318277
3.
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials.
BMC Cancer
; 21(1): 549, 2021 May 14.
Artigo
Inglês
| MEDLINE | ID: mdl-33985435
4.
Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial.
Int J Gynecol Cancer
; 31(10): 1348-1355, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34462317
5.
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
J Transl Med
; 18(1): 405, 2020 10 21.
Artigo
Inglês
| MEDLINE | ID: mdl-33087150
6.
FGFR Fusions in Cancer: From Diagnostic Approaches to Therapeutic Intervention.
Int J Mol Sci
; 21(18)2020 Sep 18.
Artigo
Inglês
| MEDLINE | ID: mdl-32962091
7.
Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials.
Gynecol Oncol
; 154(1): 83-88, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31029508
8.
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group.
Int J Gynecol Cancer
; 2022 Mar 21.
Artigo
Inglês
| MEDLINE | ID: mdl-35314461
9.
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
J Transl Med
; 19(1): 442, 2021 Oct 21.
Artigo
Inglês
| MEDLINE | ID: mdl-34674735
10.
Unlocking the potential of Molecular Tumor Boards: from cutting-edge data interpretation to innovative clinical pathways.
Crit Rev Oncol Hematol
; : 104379, 2024 May 06.
Artigo
Inglês
| MEDLINE | ID: mdl-38718940
11.
Biological and clinical impact of membrane EGFR expression in a subgroup of OC patients from the phase IV ovarian cancer MITO-16A/MANGO-OV2A trial.
J Exp Clin Cancer Res
; 42(1): 83, 2023 Apr 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37041632
12.
Non-small cell lung cancer therapy in the elderly.
Clin Adv Hematol Oncol
; 9(5): 375-83, 2011 May.
Artigo
Inglês
| MEDLINE | ID: mdl-21685866
13.
Master Protocols for Precision Medicine in Oncology: Overcoming Methodology of Randomized Clinical Trials.
Life (Basel)
; 11(11)2021 Nov 17.
Artigo
Inglês
| MEDLINE | ID: mdl-34833129
14.
Evaluation of Angiogenesis-Related Genes as Prognostic Biomarkers of Bevacizumab Treated Ovarian Cancer Patients: Results from the Phase IV MITO16A/ManGO OV-2 Translational Study.
Cancers (Basel)
; 13(20)2021 Oct 14.
Artigo
Inglês
| MEDLINE | ID: mdl-34680301
15.
Potential treatment options after first-line chemotherapy for advanced NSCLC: maintenance treatment or early second-line?
Oncologist
; 14(2): 137-47, 2009 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-19190239
16.
The use of xenograft models for the selection of cancer treatments with the EGFR as an example.
Crit Rev Oncol Hematol
; 65(3): 200-11, 2008 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-18389522
17.
Combined chemo-radiotherapy for locally advanced non-small cell lung cancer: current status and future development.
Crit Rev Oncol Hematol
; 68(3): 222-32, 2008 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-18632283
18.
The potential role of pharmacogenomic and genomic in the adjuvant treatment of early stage non small cell lung cancer.
Curr Genomics
; 9(4): 252-62, 2008 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-19452042
19.
Irreversible EGFR inhibitors in the treatment of advanced NSCLC.
Curr Pharm Des
; 20(24): 3894-900, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24138713
20.
New molecular targets in the treatment of NSCLC.
Curr Pharm Des
; 19(30): 5333-43, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-23394083